Drugs that contain Nepafenac
1. Drug name - ILEVRO
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US7947295 | NOVARTIS | Ophthalmic compositions containing a synergistic combination of two polymers |
Jun, 2024
(1 year, 8 months from now) | |
| US9662398 | NOVARTIS | Carboxylvinyl polymer-containing nanoparticle suspensions |
Dec, 2030
(8 years from now) | |
| US8921337 | NOVARTIS | Carboxyvinyl polymer-containing nanoparticle suspensions |
Mar, 2032
(9 years from now) | |
Treatment: NA
Dosage: SUSPENSION/DROPS;OPHTHALMIC
More Information on Dosage
| Strength | Dosage | Availability |
|---|---|---|
| 0.3% | SUSPENSION/DROPS;OPHTHALMIC | Prescription |
2. Drug name - NEVANAC
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US8071648 | NOVARTIS | Topical nepafenac formulations |
Dec, 2025
(3 years from now) | |
| US8324281 | NOVARTIS | Topical nepafenac formulations |
Dec, 2025
(3 years from now) | |
| US7834059 | NOVARTIS | Topical nepafenac formulations |
Jan, 2027
(4 years from now) | |
Treatment: Method of treating ocular inflammation
Dosage: SUSPENSION/DROPS;OPHTHALMIC
More Information on Dosage
| Strength | Dosage | Availability |
|---|---|---|
| 0.1% | SUSPENSION/DROPS;OPHTHALMIC | Prescription |
availability in other generic markets.
Click on the highlighted region to filter.